European leaders are warming to the idea of rolling out Russia’s Sputnik V vaccine as new research suggests that the Covid jab’s efficacy is on a par with some of those already in use.
The Week: Everything we know about Russia’s Sputnik V vaccine
A picture taken on Dec. 4, 2020, shows the production of Russia's Gam-COVID-Vac vaccine against the coronavirus disease (Covid-19) registered under trade name Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in coordination with the Russian Defense Ministry, at the facility of Russia's biotech company BIOCAD in Strelna outside Saint Petersburg.
